Hepatitis Monthly

雜志介紹

Hepatitis Monthly雜志介紹

《Hepatitis Monthly》是一本以English為主的開放獲取國際優秀期刊，中文名稱肝炎月刊，本刊主要出版、報道醫學-GASTROENTEROLOGY & HEPATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為0.3，最新CiteScore 指數為1.5。

本刊近期中國學者發表的論文主要有：

• The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir.

  Author: Wei X, Fan C, Zhou Y, Kang W, Wang J, Sun L, Wang L, Peng M, Lian J, Jia Z, Hao C.

• Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment.

  Author: Jiang L, Hu S, He M, Tian D.

• Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients.

  Author: Yu SL, Deng H, Li XH, Huang YX, Xie DY, Gao ZL.

• A Patient With Primary Biliary Cirrhosis Accompanied by Wilson's Disease.

  Author: Zhao SX, Zhang YG, Wang RQ, Li WC, Kong LB, Kong L, Nan YM.

英文介紹

Hepatitis Monthly雜志英文介紹

Hepatitis Monthly is a clinical journal which is informative to all practitioners like gastroenterologists, hepatologists and infectious disease specialists and internists. This authoritative clinical journal was founded by Professor Seyed-Moayed Alavian in 2002. The Journal context is devoted to the particular compilation of the latest worldwide and interdisciplinary approach and findings including original manuscripts, meta-analyses and reviews, health economic papers, debates and consensus statements of the clinical relevance of hepatological field especially liver diseases. In addition, consensus evidential reports not only highlight the new observations, original research, and results accompanied by innovative treatments and all the other relevant topics but also include highlighting disease mechanisms or important clinical observations and letters on articles published in the journal.